Study of Brenipatide for alcohol use disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests an injectable medicine called brenipatide to help people with moderate-to-severe alcohol use disorder reduce or stop drinking. It is for adults who are motivated to change their drinking habits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 20 years old (if in Japan) and want to cut down or stop drinking.
- You are motivated to quit or reduce alcohol use and can attend study visits.
- You are willing to give yourself injections and keep diaries or complete questionnaires.
- You do not have any other substance use disorder (except nicotine or caffeine) in the past 6 months.
- You have not had serious suicidal thoughts or behaviors in the past 6 months.
- You do not have advanced liver disease (like cirrhosis) or alcohol-related hepatitis.
- You have not taken an experimental drug in another study within the past 90 days (or 5 half-lives, whichever is longer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medicine called brenipatide to help people reduce or stop drinking. It involves getting a daily injection and completing check-ins and questionnaires over several months.
This study tests whether brexpiprazole can help adults with alcohol use disorder. You must currently not be taking alcohol-focused treatment or alcohol medicines, and you’ll likely complete questionnaires and brain scans.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This trial tests two medicines — semaglutide and naltrexone — taken together to help reduce alcohol cravings and drinking. It aims to see if this combination is more effective than standard treatment for alcohol use disorder.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.